Shared on 28 Sep 25

Fair value Increased 3.98%

Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.

Read more

0 votesShare

Shared on 08 May 25

Fair value Increased 10%

Read more

0 votesShare

Shared on 30 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 17 Apr 25

Fair value Decreased 1.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 02 Apr 25

Fair value Decreased 11%

AnalystConsensusTarget has decreased revenue growth from 2.1% to 1.7% and decreased future PE multiple from 16.2x to 14.6x.

Read more

0 votesShare

Shared on 26 Mar 25

Fair value Increased 2.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 19 Mar 25

Fair value Decreased 0.88%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 11 Mar 25

Fair value Increased 1.59%

AnalystConsensusTarget has increased revenue growth from 1.9% to 2.3%, increased future PE multiple from 14.4x to 16.3x and increased shares outstanding growth rate from -0.0% to 0.0%.

Read more

0 votesShare